Related Experiment Video
Updated: Jun 24, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.0K
Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy
Rocío Gambaro1, Ignacio Rivero Berti1,2, María José Limeres1
1Children's Hospital, University Medical Center of the Johannes, Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.
Pharmaceutics
|June 27, 2024
Summary
Researchers optimized lipid nanoparticles (LNPs) for mRNA delivery to treat metabolic diseases. Different lipid formulations showed varying inflammatory responses and mRNA expression, indicating potential for less reactogenic carriers with repetitive dosing.
Area of Science:
- Biotechnology
- Nanomedicine
- Drug Delivery Systems
Background:
- Metabolic diseases require effective therapeutic strategies.
- Lipid nanoparticles (LNPs) are a promising platform for mRNA delivery.
- Optimizing LNP formulations is crucial for therapeutic efficacy and safety.
Purpose of the Study:
- To optimize lipid nanoparticle (LNP) formulations for mRNA delivery.
- To evaluate the impact of different lipid compositions on LNP performance.
- To assess LNP suitability for treating metabolic diseases, focusing on reactogenicity and mRNA expression.
Main Methods:
- Formulation of four distinct lipid mixes (LM1-LM4) with varying lipid components.
- Characterization of LNP size, stability, and mRNA encapsulation efficiency.
- In vitro assessment of mRNA delivery to cell lines (HepG2, DC2.4) and cytokine secretion from PBMCs.
- In vivo biodistribution studies in mice following intramuscular injection.
Main Results:
- LNPs demonstrated stability, homogeneity (75-90 nm), and high mRNA encapsulation (95-100%).
- LM1, LM2, and LM4 induced significant cytokine secretion (IL-8, TNF-α, MCP-1) in PBMCs, while LM3 showed minimal induction.
- In vivo studies showed primary mRNA expression in the liver post-injection.
- Formulation modifications influenced reactogenicity, inflammatory response, and mRNA expression.
Conclusions:
- LNP component modification impacts inflammatory response and mRNA expression.
- Specific LNP formulations show potential for treating metabolic diseases.
- The study offers a platform for selecting less reactogenic carriers for repetitive dosing in metabolic disease therapy.
Related Concept Videos
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.